Skip to main content

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Active, not recruiting · Phase 2 · NCT06625060

Conditions: Episodic Migraine, Chronic Migraine

At a glance

Research payments reported, 2025
$1.7M
U.S. investigators named
36
Sites paid
42
Planned or actual enrollment
670

About the trial

Sponsor
Ipsen
Tested
Corabotase (biological), Placebo (other), Corabotase dose A (biological), Corabotase dose B (biological)
Dates
Started 2024-10-10; completion 2027-10-31
Results posted
Not yet

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Migraines are caused by a series of events when the brain gets stimulated or activated, which causes the release of chemicals that cause pain. Corabotase (also known as IPN10200) is a medication that stops the release of these chemical messengers. Participants with episodic migraine (EM) or chronic migraine (CM) will be included in both Step 1 and Step 2. "Headache days" are when participants experience headaches that meet the criteria for a migraine or a headache without the additional…

From ClinicalTrials.gov, last updated 2026-09-08. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Ipsen Innovation reported $1.7M in research payments for this study in 2025 (822 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • M3 Wake Research $173,151
  • Clinical Neuroscience Solutions, Inc $136,340
  • Integrative Clinical Trials $131,764
  • Trialsphere Clinical Research $130,952
  • Dr Bhatias Neuropain Medical Center $113,274
  • Profound Research LLC $111,743
  • Wake Research Associates $101,540
  • Ki Health PArtners, Llc $94,935
  • Delricht Research $84,041
  • Clinical Trials Management Services $83,821
  • Advanced Neurosciences Research, Llc $78,527
  • Preferred Primary Care Physicians, Inc $75,070
  • Michigan Headache and Neurological Institute $64,380
  • Neurology Diagnostics, Inc $38,045
  • Upstate Clinical Research Associates $31,861
  • $31,519
  • Conquest Research, Llc $25,500
  • Biomedical Research Alliance of New York $24,780
  • Neurology Offices South Florida $21,509
  • Kaizen Brain Center $20,800
  • Louisiana State University Health Sciences Center New Orleans $19,181
  • Alliance Clinical Network $18,050
  • Elevate Clinical Research $14,400
  • Medical Rehabilitation Group, PC $3,868
  • Emerald Coast Center for Neurological Disorders $3,611
  • Neurotrials Research $3,611
  • Javara, Inc $3,485
  • Rehabilitation & Neurological Services, LLC $3,485
  • Renstar Medical Research $3,485
  • Ochsner Health Center for Children $3,485
  • Puget Sound Neurology and Integrative Headache Center $2,211
  • The Neurology Center of Southern California $2,211
  • Southern California Neurology $419
  • Medstar Health at Brandywine Neurology $381
  • Wr-Pri Encino $126
  • Medstar Franklin Square Medical Center $126
  • Lsu Healthcare Network $126
  • Montefiore Medical Center $126
  • Cns Healthcare $126
  • M3 Wake Research Los Alamitos $126
  • Zenos Clinical Research $41
  • Cct Research PApillion Research Center $41

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.